JB Pharma, true to its market showing, did not disappoint in the month of August 2022 with a strong showing, constantly building on its investor confidence. As per the IQVIA Market Reflection Report for the month of August 2022, JB Pharma is sitting pretty, ranked at a healthy 23 among the Indian Pharmaceutical players and underlining its meteoric rise with an outstanding growth rate of 20% for the month, the highest among all other companies in the top 30 Indian Pharmaceutical companies list.

While the rest of the players in the Report show single and conservative double-digit growth, JB Pharma has raced away from the competition, proving yet again that it would be just a matter of time before they would be counted among the top 20 Indian Pharma big guns. The Report specifically states that on both counts of TSA (Total Sales Audit) and SSA (Secondary Sales Audit) numbers, JB Pharma performed admirably well posting the highest growth for the month of August 2022 and also posted the highest growth for MAT (Moving Annual Total) for the 12-month period ending with August 2022.